Overview
Nipah virus (NiV) is a highly lethal zoonotic pathogen causing severe neurological disease with high mortality rates, posing significant threats to human and animal health 123. No proven post-exposure treatments exist, highlighting the urgent need for vaccine development 1.Diagnosis
Management
Special Populations
Key Recommendations
References
1 Sharma S, Yadav PD, Cherian S. Comprehensive immunoinformatics and bioinformatics strategies for designing a multi-epitope based vaccine targeting structural proteins of Nipah virus. Frontiers in immunology 2025. link 2 Masum MHU, Mahdeen AA, Barua L, Parvin R, Heema HP, Ferdous J. Developing a chimeric multiepitope vaccine against Nipah virus (NiV) through immunoinformatics, molecular docking and dynamic simulation approaches. Microbial pathogenesis 2024. link 3 Banico EC, Sira EMJS, Fajardo LE, Dulay ANG, Odchimar NMO, Simbulan AM et al.. Advancing one health vaccination: In silico design and evaluation of a multi-epitope subunit vaccine against Nipah virus for cross-species immunization using immunoinformatics and molecular modeling. PloS one 2024. link 4 Shahab M, Iqbal MW, Ahmad A, Alshabrmi FM, Wei DQ, Khan A et al.. Immunoinformatics-driven In silico vaccine design for Nipah virus (NPV): Integrating machine learning and computational epitope prediction. Computers in biology and medicine 2024. link 5 Sahay RR, Yadav PD, Gupta N, Shete AM, Radhakrishnan C, Mohan G et al.. Experiential learnings from the Nipah virus outbreaks in Kerala towards containment of infectious public health emergencies in India. Epidemiology and infection 2020. link